{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:59:39Z","timestamp":1781243979480,"version":"3.54.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the association between uterine leiomyomas (UL) and specific alterations in serum lipid profiles, and to evaluate the performance of machine learning models incorporating these markers for UL discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this age- and body mass index matched case-control study, 200 patients with histologically confirmed UL and 200 controls with normal uteri were enrolled. Fasting serum levels of total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, apolipoprotein A1 (ApoA1), and apolipoprotein B were measured. Logistic regression identified independent risk factors, which were then used to construct predictive models via several machine learning algorithms. Model performance was assessed using receiver operating characteristic curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with UL exhibited significantly lower serum levels of triglycerides and ApoA1 compared to controls. Multivariate analysis confirmed lower triglyceride and ApoA1 levels, along with higher gravidity and premenopausal status, as independent factors associated with UL. While individual lipid parameters showed limited discriminative power, integrative models combining these with clinical features achieved high performance. The Random Forest model demonstrated superior discriminative ability, with an area under the curve of 0.986.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After rigorous confounding control, UL is independently associated with a distinct metabolic phenotype characterized by reduced serum triglyceride and ApoA1 levels. Prediction models integrating these lipid abnormalities with clinical data show promising potential for risk assessment, highlighting a unique interplay between lipid metabolism and UL pathogenesis worthy of further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1866505","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:45:44Z","timestamp":1781243144000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered lipid profile in uterine leiomyoma: a focus on apolipoprotein A1 reduction and machine learning-based predictive modeling"],"prefix":"10.3389","volume":"13","author":[{"given":"Feifei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsha","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/humrep\/deae162","article-title":"First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000\u20132022.","volume":"39","author":"Wilson","year":"2024","journal-title":"Hum Reprod."},{"key":"B2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/humrep\/dead020","article-title":"Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma.","volume":"38","author":"Li","year":"2023","journal-title":"Hum Reprod."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/AOG.0000000000004997","article-title":"Ultrasound-confirmed, age-specific uterine leiomyoma incidence in a cohort of black individuals.","volume":"140","author":"Wegienka","year":"2022","journal-title":"Obstet Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment.","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1097\/CM9.0000000000002971","article-title":"Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: a worldwide database study.","volume":"137","author":"Dai","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias.","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2205524119","DOI":"10.1073\/pnas.2205524119","article-title":"Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis.","volume":"119","author":"Cloud","year":"2022","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.fertnstert.2024.02.046","article-title":"Functional evidence for two distinct mechanisms of action of progesterone and selective progesterone receptor modulator on uterine leiomyomas.","volume":"122","author":"Milewska","year":"2024","journal-title":"Fertil Steril."},{"key":"B9","doi-asserted-by":"publisher","first-page":"120708","DOI":"10.1016\/j.lfs.2022.120708","article-title":"Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas.","volume":"304","author":"Afrin","year":"2022","journal-title":"Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/uog.27535","article-title":"Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study.","volume":"63","author":"De Bruyn","year":"2024","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"111858","DOI":"10.1016\/j.mad.2023.111858","article-title":"Lipids and the hallmarks of ageing: from pathology to interventions.","volume":"215","author":"Sharma","year":"2023","journal-title":"Mech Ageing Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"102314","DOI":"10.1016\/j.arr.2024.10231","article-title":"Senescence-associated secretory phenotype (SASP) and uterine fibroids: association with PD-L1 activation and collagen deposition.","volume":"97","author":"Saad","year":"2024","journal-title":"Ageing Res Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","article-title":"Leveraging knowledge of HDLs major protein ApoA1: structure, function, mutations, and potential therapeutics.","volume":"154","author":"Bhale","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/antiox14111362","article-title":"Dysfunction of the ABCA1 and ABCG1 transporters and their impact on HDL metabolism.","volume":"14","author":"Laguna-Maldonado","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11883-025-01308-9","article-title":"High density lipoprotein particle composition, functionality, deficiency, and atherosclerotic cardiovascular disease risk: a review.","volume":"27","author":"Schaefer","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/postmj\/qgae011","article-title":"The association of circulating lipoprotein lipids and apolipoproteins with risk of endometriosis: a Mendelian randomization study.","volume":"100","author":"He","year":"2024","journal-title":"Postgrad Med J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105856","DOI":"10.1016\/j.phrs.2021.105856","article-title":"Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation.","volume":"172","author":"Afrin","year":"2021","journal-title":"Pharmacol Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.7150\/ijbs.83510","article-title":"Integrating spatial transcriptomics and single-nucleus RNA sequencing reveals the potential therapeutic strategies for uterine leiomyoma.","volume":"19","author":"Wang","year":"2023","journal-title":"Int J Biol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/humupd\/dmac008","article-title":"Epigenomic and enhancer dysregulation in uterine leiomyomas.","volume":"28","author":"Mlodawska","year":"2022","journal-title":"Hum Reprod Update."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jcsm.12832","article-title":"Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study.","volume":"12","author":"Kamper","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B21","doi-asserted-by":"publisher","first-page":".392.e1","DOI":"10.1016\/j.ajog.2021.05.005","article-title":"The environment, leiomyomas, latinas, and adiposity study: rationale and design.","volume":"226","author":"Manuel","year":"2022","journal-title":"Am J Obstet Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/2326-6066.CIR-23-0506","article-title":"Low serum apolipoprotein A1 levels impair antitumor immunity of CD8+ T cells via the HIF-1\u03b1 -glycolysis pathway.","volume":"12","author":"Lv","year":"2024","journal-title":"Cancer Immunol Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1038\/s41467-023-39683-z","article-title":"Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma.","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"120238","DOI":"10.1016\/j.lfs.2021.120238","article-title":"Differential response to hypoxia in leiomyoma and myometrial cells.","volume":"290","author":"Miyashita-Ishiwata","year":"2022","journal-title":"Life Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41389-022-00425-3","article-title":"A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase.","volume":"11","author":"Mehine","year":"2022","journal-title":"Oncogenesis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/AOG.0000000000005475","article-title":"Establishment of noninvasive prediction models for the diagnosis of uterine leiomyoma subtypes.","volume":"143","author":"Tamehisa","year":"2024","journal-title":"Obstet Gynecol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1866505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:45:49Z","timestamp":1781243149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1866505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":26,"alternative-id":["10.3389\/fmed.2026.1866505"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1866505","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"article-number":"1866505"}}